Other Events ·
Matinas BioPharma Holdings, Inc. received a June 24, 2026, notice from the NYSE American LLC that it is non-compliant…
MTNBMatinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. received a June 24, 2026, notice from the NYSE American LLC that it is non-compliant with stockholders' equity listing standards. The company's stockholders' equity was $3,022,000 as of March 31, 2026, falling below the required $4.0 million threshold. The NYSE American has accepted the company's plan to regain compliance, granting a plan period through October 2, 2027, to meet the requirements. Matinas BioPharma Holdings, Inc. is a biopharmaceutical company focused on developing RNA-based therapeutics.